Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 160

    1.

    Evaluation and management of HIV-infected women.

    Levine AM.

    Ann Intern Med. 2002 Feb 5;136(3):228-42. Review.PMID: 11827499 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.

    Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for the Treatment of HIV.

    MMWR Recomm Rep. 2002 May 17;51(RR-7):1-55.PMID: 12027060 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.

    Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for Treatment of HIV.

    Ann Intern Med. 2002 Sep 3;137(5 Pt 2):381-433.PMID: 12617573 [PubMed - indexed for MEDLINE]Related articles

    4.

    Risk factors, diagnosis and prognosis of cervical intraepithelial neoplasia among HIV-infected women.

    Lehtovirta P, Paavonen J, Heikinheimo O.

    Int J STD AIDS. 2008 Jan;19(1):37-41.PMID: 18275645 [PubMed - indexed for MEDLINE]Related articles

    5.

    U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.

    Mofenson LM; Centers for Disease Control and Prevention, U.S. Public Health Service Task Force.

    MMWR Recomm Rep. 2002 Nov 22;51(RR-18):1-38; quiz CE1-4.PMID: 12489844 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update January 2007)]

    Panel de expertos de GESIDA; Plan Nacional sobre el Sida.

    Enferm Infecc Microbiol Clin. 2007 Jan;25(1):32-53. Spanish. PMID: 17261244 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Continuation of postpartum antiretroviral therapy in a cohort of women infected with human immunodeficiency virus.

    Tedaldi E, Willard S, Gilmore J, Holdsworth C, Dix-Lassiter S, Axelrod P.

    J Assoc Nurses AIDS Care. 2002 Jan-Feb;13(1):60-5.PMID: 11828860 [PubMed - indexed for MEDLINE]Related articles

    8.

    Daily low-dose subcutaneous interleukin-2 added to single- or dual-nucleoside therapy in HIV infection does not protect against CD4+ T-cell decline or improve other indices of immune function: results of a randomized controlled clinical trial (ACTG 248).

    Vogler MA, Teppler H, Gelman R, Valentine F, Lederman MM, Pomerantz RJ, Pollard RB, Cherng DW, Gonzalez CJ, Squires KE, Frank I, Mildvan D, Mahon LF, Schock B; AIDS Clinical Trials Group 248 Study Team.

    J Acquir Immune Defic Syndr. 2004 May 1;36(1):576-87.PMID: 15097300 [PubMed - indexed for MEDLINE]Related articles

    9.

    Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.

    Sánchez-Ramón S, Bellón JM, Resino S, Cantó-Nogués C, Gurbindo D, Ramos JT, Muñoz-Fernández MA.

    Pediatrics. 2003 Feb;111(2):E168-75.PMID: 12563091 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Highly active antiretroviral therapy and incidence of cervical squamous intraepithelial lesions among HIV-infected women with normal cytology and CD4 counts above 350 cells/mm3.

    Sirera G, Videla S, López-Blázquez R, Llatjos M, Tarrats A, Castellà E, Grane N, Tural C, Rey-Joly C, Clotet B.

    J Antimicrob Chemother. 2008 Jan;61(1):191-4. Epub 2007 Oct 31.PMID: 17977910 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Lopinavir/ritonavir: a review of its use in the management of HIV infection.

    Cvetkovic RS, Goa KL.

    Drugs. 2003;63(8):769-802. Review.PMID: 12662125 [PubMed - indexed for MEDLINE]Related articles

    12.

    API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.

    Gupta SB, Pujari SN, Joshi SR, Patel AK; AIDS Society of India Guidelines Development Committee.

    J Assoc Physicians India. 2006 Jan;54:57-74. Review.PMID: 16649742 [PubMed - indexed for MEDLINE]Related articles

    13.

    Epidemiological and clinical features, response to HAART, and survival in HIV-infected patients diagnosed at the age of 50 or more.

    Nogueras M, Navarro G, Antón E, Sala M, Cervantes M, Amengual M, Segura F.

    BMC Infect Dis. 2006 Nov 6;6:159.PMID: 17087819 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl.

    Wood E, Hogg RS, Yip B, Moore D, Harrigan PR, Montaner JS.

    AIDS. 2006 May 12;20(8):1117-23.PMID: 16691062 [PubMed - indexed for MEDLINE]Related articles

    15.

    Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART.

    Collazos J, Asensi V, Cartón JA.

    AIDS. 2007 Apr 23;21(7):835-43.PMID: 17415038 [PubMed - indexed for MEDLINE]Related articles

    16.

    Effect of persistent moderate viremia on disease progression during HIV therapy.

    Raffanti SP, Fusco JS, Sherrill BH, Hansen NI, Justice AC, D'Aquila R, Mangialardi WJ, Fusco GP; Collaborations in HIV Outcomes Research/United States Project.

    J Acquir Immune Defic Syndr. 2004 Sep 1;37(1):1147-54.PMID: 15319674 [PubMed - indexed for MEDLINE]Related articles

    17.

    Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.

    Bedell R, Heath KV, Hogg RS, Wood E, Press N, Yip B, O'Shaughnessy MV, Montaner JS.

    Antivir Ther. 2003 Oct;8(5):379-84.PMID: 14640384 [PubMed - indexed for MEDLINE]Related articles

    18.

    Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.

    Hershow RC, O'Driscoll PT, Handelsman E, Pitt J, Hillyer G, Serchuck L, Lu M, Chen KT, Yawetz S, Pacheco S, Davenny K, Adeniyi-Jones S, Thomas DL.

    Clin Infect Dis. 2005 Mar 15;40(6):859-67. Epub 2005 Feb 18.PMID: 15736020 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Spanish GESIDA/Nacional AIDS Plan Recommendations for antiretroviral therapy in HIV-infected Adults (October 2004)]

    Iribarren JA, Labarga P, Rubio R, Berenguer J, Miró JM, Antela A, González J, Moreno S, Arrizabalaga J, Chamorro L, Clotet B, Gatell JM, López-Aldeguer J, Martínez E, Polo R, Tuset M, Viciana P, Santamaría JM, Kindelán JM, Ribera E, Segura F; Grupo de Estudio de Sida; Consejo Asesor Clínico del Plan Nacional sobre el Sida del Ministerio de Sanidad y Consumo.

    Enferm Infecc Microbiol Clin. 2004 Dec;22(10):564-642. Spanish. PMID: 15596051 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France.

    Breton G, Lewden C, Spire B, Salmon D, Brun-Vézinet F, Duong M, Allavena C, Leport C, Salamon R; APROCO COPILOTE ANRS CO8 Study Group.

    HIV Med. 2007 Apr;8(3):164-70.PMID: 17461860 [PubMed - indexed for MEDLINE]Related articles